Best Burkitt"s lymphoma doctors in Israel: TOP 20 doctors

Dr. Ram Ron treats Burkitt's lymphoma at the Sourasky Medical Center (Ichilov), one of Israel's largest and most advanced hospitals.

• More than 24 years of experience of experience in medical oncology
• Holds a fellowship from a leading international center for reproductive medicine
• Treats with a range of procedures including intrauterine insemination
• Educated at the University of Mysore in India

Performed several hundred stem cell transplants – a key treatment for aggressive lymphomas. Dr. Ram is a triple board-certified hematologist-oncologist based at Ichilov Hospital.

• Over 30 published articles and a textbook chapter on blood cancers
• Fellowship-trained at New York Medical College in hematology and oncology
• Holds board certifications in internal medicine, hematology, and medical oncology

Head of Pediatric Oncohematology at Dana Dwek Children’s Hospital – Dr. El Hasid specializes in bone marrow and umbilical blood transplants for children.

• Performed 300+ transplant procedures
• Published 50+ research papers in pediatric oncology
• Member of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive experience treating blood cancers.

• Graduated from Hebrew University Medical School
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah

Dr. Fredi Aviv has over 34 years of experience of experience treating blood cancers at Tel Aviv's leading Sourasky Medical Center.

• 34 years of experience dedicated to oncohematology
• Specializes in aggressive blood cancers
• Practices at the renowned Sourasky Medical Center
• Expertise in the latest medical and biological therapies

Dr. Dror Levin specializes in pediatric hematology oncology, focusing on Burkitt's lymphoma at Sourasky Medical Center in Tel Aviv.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology Oncology (ISPHO)
• Studied bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

A leading hematology expert recognized by the American Society of Hematology, Dr. Yair treats patients at Tel Aviv's Sourasky Medical Center.

• Specialized residency in hematology at Tel Aviv Medical Center
• Winner of multiple research grants and awards for clinical excellence
• Active member of both the Israeli and American Hematology Associations
• Focus on leukemia research, including lymphocytic forms

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Specializes in oncohematology, treating cancers of the blood and lymphatic system at Assuta Medical Center.

• Focuses exclusively on hematologic malignancies like Burkitt's lymphoma
• Provides expert diagnosis and treatment planning for complex blood cancers
• Works within Israel's renowned Assuta hospital network

Over 3,500 bone marrow transplants performed – Dr. Stepensky is recognized by Forbes as one of the best doctors.

• 28 years of experience of practice specializing in pediatric hematology
• Expert in treating children with rare blood cancers like Burkitt's lymphoma
• Practices at Hadassah Medical Center in Israel
• Known for a high level of expertise and compassionate care

Professor Zila Zuckerman is a Hematology and Transplantology specialist focusing on blood cancers at Rambam Medical Center.

• Subspecialist in transplantology for blood disorders
• Academic professor with research-level expertise
• Works at a leading national medical center

Specializes in the treatment of lymphomas at Rambam Medical Center.

• Focuses on hematology with extensive experience in lymphoma cases
• Works at a leading medical center known for oncology care
• Dedicated to providing personalized treatment plans for patients

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.